Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Akesobio
Welcome,
Profile
Billing
Logout
2 Products
0 Diseases
2 Products
2 Trials
5 News
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
27
54
81
108
135
162
189
216
243
270
Kaitanni
(cadonilimab) / Akesobio
Anniko
(penpulimab) / Akesobio, Sino Biopharm
Yidafan
(ivonescimab) / Akesobio, Summit Therapeutics
ligufalimab
(AK117) / Akesobio
ebronucimab
(AK102) / Akesobio
manfidokimab
(AK120) / Akesobio
drebuxelimab
(AK119) / Akesobio
gumokimab
(AK111) / Akesobio
tagitanlimab
(HBM9167) / Harbour BioMed
ebdarokimab
(AK101) / Akesobio
lancastotug
(AK127) / Akesobio
pulocimab
(AK109) / Akesobio
quavonlimab
(MK-1308) / Merck (MSD)
AK129
/ Akesobio
lucorafusp alfa
(AK130) / Akesobio
AK114
/ Akesobio
AK131
/ Akesobio
